FMC Corp vs SpaceX — how do they compare? FMC Corp trades at $11.46 (market cap $1.36B), while SpaceX trades at $135.24 (market cap $1.78T). The key difference: SpaceX is far larger — about 1308.8× FMC Corp's market cap, and FMC Corp pays a 2.95% dividend while SpaceX pays none. Which is the better fit depends on your goals.
| FMC | SPCX | |
|---|---|---|
Market Cap | $1.36B | $1.78T |
Sector | Basic Materials | Technology |
52-Week High | $43.90 | $202.09 |
52-Week Low | $10.72 | $135.00 |
Enterprise Value | $5.50B | $1.80T |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
SPCX trades at $134.95, down 0.83% and below its $135 IPO price for the first time. The stock shows bearish technical signals with negative earnings momentum (Q1 2026 EPS miss of -$1.19 vs -$0.33 expected) and widening losses (2026 net profit margin projected at -45%). Despite 100% analyst buy ratings and a $241.50 consensus target, high valuations (P/S 91.64, EV/EBITDA 951.8) and accelerating capital expenditures create significant investor skepticism.
The outlook remains challenged by substantial operational losses and cash burn, though long-term growth potential in space technology offers speculative upside. Key risks include execution on costly projects, competitive pressure, and dependency on future revenue streams to justify current valuation.
Trailing returns across standard periods
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →